Clinical trial
Combination Chemotherapy Plus Biological Therapy in Treating Patients With…
NCT00004141 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00004141 |
|---|---|
| Title | Combination Chemotherapy Plus Biological Therapy in Treating Patients With Metastatic Melanoma |
| Official title | Phase II Study of Outpatient CDDP and DTIC Followed by GM-CSF, IFN-a2b, and IL-2 in Patients With Advanced Melanoma |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Drug |
| Interventions | Cisplatin, dacarbazine, Granulocyte-macrophage colony-stimulating factor |
| Enrollment | 46 |
| Start date | Aug 1, 1998 |
| Primary completion | Jan 1, 2003 |
| Completion | Apr 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: